Replies to post #194204 on Biotech Values

[DewDiligence]

(INO)—AZN testing Imfinzi/MEDI0457 combo in second-line H&N cancer:

https://finance.yahoo.com/news/inovio-provides-medimmune-launch-combination-120000238.html

MEDI0457 (f/k/a INO-3112) is a cancer vaccine targeting HPV-associated tumors, which AZN licensed in Aug 2015 (#msg-116078700).